Journal Watch: Biomarkers of the innate immune system predict progression to Alzheimer’s disease

Written by David Howett, University of Cambridge, UK

Research led by Svetlana Hakobyan at Cardiff University (UK) examined the potential of developing biomarkers from the innate immune system in the detection of Alzheimer’s disease (AD) in blood samples. The research, published in September 2016 by The Journal of Alzheimer’s Disease, trained and applied a statistical model on a variety of disease states. The apolipoprotein clusterin best predicted progression from mild cognitive impairment (MCI) to AD and differentiated AD from healthy controls (HCs). Previous attempts to establish plasma biomarkers for assisting the diagnosis of AD have been unsuccessful, yet the successful development of therapeutic interventions aiming to inhibit disease...

To view this content, please register now for access

It's completely free